No Data
No Data
Unusual Options Activity: APA, GNRC and Others Attract Market Bets, APA V/OI Ratio Reaches 868.8
EST Jul 1st Afternoon Delivery - In the last two hours of trading, 5 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trends.
Jefferies Maintains Intra-Cellular Therapies(ITCI.US) With Buy Rating, Maintains Target Price $105
Jefferies analyst Andrew Tsai maintains $Intra-Cellular Therapies(ITCI.US)$ with a buy rating, and maintains the target price at $105.According to TipRanks data, the analyst has a success rate of 51.6
Intra-Cellular Therapies(ITCI.US) Director Sells US$337.19K in Common Stock
$Intra-Cellular Therapies(ITCI.US)$ Director RIGGS RORY B sold 4,462 shares of common stock on Jun 24, 2024 at an average price of $75.57 for a total value of $337.19K.Source: Announcement What is sta
UBS Downgrades Intra-Cellular Therapies to Neutral, Lowers Price Target to $83
UBS Downgrades Intra-Cellular Therapies(ITCI.US) to Hold Rating, Raises Target Price to $83
UBS analyst Ashwani Verma downgrades $Intra-Cellular Therapies(ITCI.US)$ to a hold rating, and adjusts the target price from $80 to $83.According to TipRanks data, the analyst has a success rate of 43
RBC Capital Reiterates Outperform on Intra-Cellular Therapies, Maintains $103 Price Target